机构:[1]Faculty of Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Taipa, Macao, PR China.[2]Institute of Consun Co. for Chinese Medicine in Kidney Diseases, Guangdong Consun Pharmaceutical Group, Dongpeng Road 71, Guangzhou, PR China.[3]School of Pharmacy, State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Taipa, Macao, PR China.[4]Department of Endocrinology, Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine, Zhuhai, PR China.[5]Macau University of Science and Technology Zhuhai MUST Science and Technology Research Institute, Hengqin, Zhuhai, PR China.
Science and Technology Development Fund of Macau [0025/2019/AGJ & 0055/2019/AMJ].Department of Science and Technology of Guangdong Province [2020A050515013].
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类|4 区综合性期刊
小类|4 区综合性期刊
最新[2025]版:
大类|4 区综合性期刊
小类|4 区综合性期刊
第一作者:
第一作者机构:[1]Faculty of Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Taipa, Macao, PR China.
共同第一作者:
通讯作者:
通讯机构:[1]Faculty of Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Taipa, Macao, PR China.[3]School of Pharmacy, State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Taipa, Macao, PR China.[4]Department of Endocrinology, Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine, Zhuhai, PR China.[5]Macau University of Science and Technology Zhuhai MUST Science and Technology Research Institute, Hengqin, Zhuhai, PR China.[*1]Faculty of Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Taipa, Macao, PR China.
推荐引用方式(GB/T 7714):
Zhao Tingting,Xiang Qian,Lie Beifeng,et al.Yishen Huashi granule modulated lipid metabolism in diabetic nephropathy via PI3K/AKT/mTOR signaling pathways[J].Heliyon.2023,9(3):e14171.doi:10.1016/j.heliyon.2023.e14171.
APA:
Zhao Tingting,Xiang Qian,Lie Beifeng,Chen Deqi,Li Minyi...&Xu Youhua.(2023).Yishen Huashi granule modulated lipid metabolism in diabetic nephropathy via PI3K/AKT/mTOR signaling pathways.Heliyon,9,(3)
MLA:
Zhao Tingting,et al."Yishen Huashi granule modulated lipid metabolism in diabetic nephropathy via PI3K/AKT/mTOR signaling pathways".Heliyon 9..3(2023):e14171